Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 14, 2022

SELL
$0.63 - $1.59 $73,132 - $184,571
-116,083 Closed
0 $0
Q4 2021

Jan 12, 2022

SELL
$1.27 - $2.42 $6,997 - $13,334
-5,510 Reduced 4.53%
116,083 $147,000
Q3 2021

Oct 07, 2021

BUY
$2.15 - $3.82 $21,113 - $37,512
9,820 Added 8.79%
121,593 $265,000
Q2 2021

Jul 12, 2021

BUY
$2.89 - $4.45 $37,570 - $57,850
13,000 Added 13.16%
111,773 $419,000
Q1 2021

Apr 09, 2021

SELL
$2.9 - $4.09 $42,949 - $60,572
-14,810 Reduced 13.04%
98,773 $321,000
Q4 2020

Jan 08, 2021

SELL
$3.38 - $5.14 $76,895 - $116,935
-22,750 Reduced 16.69%
113,583 $387,000
Q3 2020

Oct 05, 2020

BUY
$2.99 - $4.9 $92,211 - $151,116
30,840 Added 29.23%
136,333 $556,000
Q2 2020

Jul 06, 2020

BUY
$2.11 - $3.38 $11,773 - $18,860
5,580 Added 5.58%
105,493 $356,000
Q1 2020

Apr 06, 2020

BUY
$1.83 - $3.45 $26,736 - $50,404
14,610 Added 17.13%
99,913 $232,000
Q4 2019

Jan 07, 2020

SELL
$3.5 - $10.35 $4,872 - $14,407
-1,392 Reduced 1.61%
85,303 $310,000
Q3 2019

Oct 02, 2019

BUY
$7.03 - $9.7 $354,909 - $489,704
50,485 Added 139.42%
86,695 $719,000
Q2 2019

Jul 23, 2019

BUY
$7.36 - $11.26 $5,056 - $7,735
687 Added 1.93%
36,210 $311,000
Q1 2019

Apr 09, 2019

BUY
$9.08 - $11.84 $14,210 - $18,529
1,565 Added 4.61%
35,523 $379,000
Q4 2018

Jan 10, 2019

BUY
$6.39 - $16.99 $10,192 - $27,099
1,595 Added 4.93%
33,958 $297,000
Q3 2018

Oct 09, 2018

BUY
$16.52 - $24.82 $28,992 - $43,559
1,755 Added 5.73%
32,363 $543,000
Q2 2018

Jul 10, 2018

BUY
$14.31 - $21.75 $19,604 - $29,797
1,370 Added 4.69%
30,608 $641,000
Q1 2018

Apr 19, 2018

BUY
$16.09 - $23.07 $179,564 - $257,461
11,160 Added 61.73%
29,238 $470,000
Q4 2017

Jan 19, 2018

BUY
$13.36 - $20.73 $44,355 - $68,823
3,320 Added 22.5%
18,078 $342,000
Q3 2017

Oct 16, 2017

BUY
$8.75 - $14.07 $129,132 - $207,645
14,758
14,758 $207,000

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0

About SPECTRUM PHARMACEUTICALS INC


  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.